ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,194 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZugBridgeBio International GmbH
BridgeBio International GmbH Logo
Verified· 2 sources

BridgeBio International GmbH

Summary

About the company

BridgeBio International GmbH is a biopharmaceutical company that develops medicines for genetic conditions and manages a pipeline of investigational candidates and approved therapies. The organization uses a hub‑and‑spoke model, partners with academic institutions, and conducts clinical research and trials.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered7
Research and Development Pipeline
Late-stage and preclinical development of medicines for genetic diseases, including Acoramidis, BBP-418, Encaleret, Infigratinib, BBP-812 and Depleter.
Approved Medicines
Marketed medicines Attruby® (acoramidis) and NULIBRY® (fosdenopterin) for genetic and rare diseases.
Clinical Studies
Clinical studies on rare genetic diseases, including ACT-EARLY, PROPEL and ACCEL, to evaluate investigational therapies and their effectiveness.
Research and Publications
Scientific presentations, publications and peer-reviewed materials on molecules, diseases and research types in the field of rare genetic diseases.
Genetic Testing Programmes
Genetic Testing Programme for ADH1 and hypoparathyroidism, with separate information for patients and healthcare professionals.
Patient Access Support
Support after the prescription of BridgeBio medicines: insurance navigation, financial assistance, specialty-pharmacy handling and ongoing guidance.
Patient Support and Advocacy Information
Referrals to support and advocacy organizations for ATTR-CM, ATTRv, Achondroplasia, Hypochondroplasia, LGMD2I/R9, ADH1 and Canavan Disease.
Comparisons

BridgeBio International GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank BridgeBio International GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of BridgeBio International GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Landis + Gyr-Strasse 1
6300 Zug

At a glance

Legal form
Limited Liability Company
UID
CHE-422.229.719
Founded
2024 · 2 years
Last commercial register change
October 22, 2025
Employees
1 to 10

Knowledge

No knowledge articles yet

Once BridgeBio International GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

CP
Crinetics Pharmaceuticals Europe GmbH
Zug
KP
KalVista Pharmaceuticals Switzerland GmbH
Zug
NT
Nektar Therapeutics Europe GmbH
Zug
IS
Insmed Switzerland GmbH
Zug
KP
Kiniksa Pharmaceuticals, GmbH
Zug
SI
Sarepta International Holdings GmbH
Zug
TP
Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug
Zug
ST
SpringWorks Therapeutics Europe GmbH
Zug